XML 86 R77.htm IDEA: XBRL DOCUMENT v3.24.3
Investments in and Advances to Joint Ventures - Summary of Financial Information for Unconsolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 2,554,658   $ 2,554,658   $ 2,137,526
Total assets 5,443,342   5,443,342   4,804,061
Current liabilities 1,649,554   1,649,554   1,410,884
Total liabilities 3,028,911   3,028,911   2,427,346
Total joint venture equity 2,312,452   2,312,452   2,287,211
Investments in and advances to unconsolidated joint ventures 194,524   194,524   128,204
Revenue 1,810,116 $ 1,418,571 5,016,259 $ 3,948,523  
Costs 1,449,831 1,124,305 3,979,589 3,109,713  
Net (loss) income attributable to Parsons Corporation 71,951 47,447 33,768 116,241  
Equity in losses of unconsolidated joint ventures 872 10,262 (18,025) 4,497  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 1,675,165   1,675,165   1,607,953
Noncurrent assets 465,806   465,806   483,693
Total assets 2,140,971   2,140,971   2,091,646
Current liabilities 996,238   996,238   1,057,113
Noncurrent liabilities 496,097   496,097   518,647
Total liabilities 1,492,335   1,492,335   1,575,760
Total joint venture equity 648,636   648,636   515,886
Investments in and advances to unconsolidated joint ventures 194,524   194,524   $ 128,204
Revenue 581,232 634,937 1,598,764 1,514,561  
Costs 560,492 581,041 1,593,213 1,474,991  
Net (loss) income attributable to Parsons Corporation 20,740 53,896 5,551 39,570  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Equity in losses of unconsolidated joint ventures $ 872 $ 10,262 $ (18,025) $ 4,497